Clinical Trials Browser

Giant Cell Tumor of Bone × Denosumab × 1 year × Clear all

NCT04586660 2025-10-01

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Phase 4 Active not recruiting

Giant Cell Tumor of Bone